Tnf Pharmaceuticals, Inc.

Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Skeena Gold & Silver Announces Pricing of US$750 Million Senior Secured Notes Offering to Refinance Former Project Financing and to Fund Partial Buyback of Existing Gold Stream

Magna Mining Files Technical Report for the McCreedy West Mine in Sudbury, Ontario

Lindsay Corporation Reports Fiscal 2026 Second Quarter Results

European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Received One or Two Prior Systemic Treatment Regimens